Effect of Highly Bioavailable Curcumin on Subjective Tinnitus

Status unconfirmed · Not applicable · Has a placebo group

Conditions studied: Tinnitus, Subjective

In brief

This study will assess the effectiveness of highly bioavailable curcumin in suppressing subjective tinnitus based on pre- and post-treatment evaluations using the validated Tinnitus Functional Index (TFI) and Tinnitus Handicap Inventory (THI) surveys.

Key facts

Study ID

NCT04800107

Run by

Henry Ford Health System

People needed

110

Starts

2021-01-06

Expected to finish

2025-12-31

Last updated by the study team

2023-04-20

Who can join

Age: 18 and older, up to 99. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Adults with subjective tinnitus due to sensorineural hearing loss as determined by routine audiogram.

You may not qualify if…

• Adults with subjective tinnitus due to another cause
• Sensitivity or allergy to test compounds
• Use of other off-label medications, substances, treatments specifically for tinnitus mitigation (e.g., anti-depressant/anxiety medications, GABA-inhibitors, psychiatric-based interventions/counseling)
• Pregnancy
• Patients taking anticoagulants to minimize risk of drug-drug interactions.

Where it is running

• Michigan Ear Institute — Farmington Hills, Michigan, United States
• Michigan Ear Institute — Novi, Michigan, United States
• Michigan Ear Institute — Royal Oak, Michigan, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.